Desferal

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1964-2017
0102019642017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The aim of the present study was to investigate whether the iron chelator Desferal prevents the degeneration of dopaminergic… (More)
Is this relevant?
2005
2005
Desferal is a clinically approved iron chelator used to treat iron overload. Doxorubicin is an anthracycline cancer chemotherapy… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
In Parkinson's disease (PD) and its neurotoxin-induced models, 6-hydroxydopamine (6-OHDA) and N-methyl-4-phenyl-1,2,3,6… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The viable counts of Salmonella typhimurium on nutrient agar (NA) decreased upon the addition of either the essential oil of… (More)
Is this relevant?
1992
1992
Zirconium-desferal was prepared and analysed by TLC, NMR and u.v.-spectroscopy. The stoichiometry of the complex was found to be… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
A selective increase in content of iron in the pars compacta of the substantia nigra has been implicated in the biochemical… (More)
Is this relevant?
1987
1987
Desferrioxamine mesylate (Desferal), a transition metal ion chelator, has been used to inhibit the in vitro redox cycling of… (More)
Is this relevant?
1985
1985
The iron chelator desferal is a powerful inhibitor of lipid peroxidation and of hydroxyl radical formation dependent on the… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
The catalysis by iron of the formation of reactive oxygen species in biological systems has been well documented. In this present… (More)
Is this relevant?
1984
1984
Eight patients (16 eyes) developed ocular toxicity while undergoing intravenous deferoxamine mesylate (Desferal) chelation… (More)
Is this relevant?